Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000572870 | SCV000671703 | pathogenic | Hereditary cancer-predisposing syndrome | 2016-11-18 | criteria provided, single submitter | clinical testing | The c.783_784delGA pathogenic mutation, located in coding exon 7 of the PTEN gene, results from a deletion of two nucleotides at nucleotide positions 783 to 784, causing a translational frameshift with a predicted alternate stop codon. This mutation (designated as deletion of GA in N262) was identified in a 33 year-old male patient with Lhermitte-Duclos disease, macrocephaly, and Cowden syndrome-related skin abnormalities (Nelen MR et al. Hum. Mol. Genet. 1997 Aug;6:1383-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |